Geert Cauwenbergh
2022
In 2022, Geert Cauwenbergh earned a total compensation of $77.4K as Former interim Principal Executive and Financial Officer at RXi Pharmaceuticals, a 33% increase compared to previous year.
Compensation breakdown
| Salary | $68,750 |
|---|---|
| Stock Awards | $8,612 |
| Total | $77,362 |
Cauwenbergh received $68.8K in salary, accounting for 89% of the total pay in 2022.
Cauwenbergh also received $8.6K in stock awards.
Rankings
In 2022, Geert Cauwenbergh's compensation ranked 5,625th out of 5,736 executives tracked by ExecPay. In other words, Cauwenbergh earned more than 1.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,625 out of 5,736 | 2nd |
Division Manufacturing | 3,073 out of 3,125 | 2nd |
Major group Chemicals And Allied Products | 1,398 out of 1,416 | 1st |
Industry group Drugs | 1,303 out of 1,317 | 1st |
Industry Pharmaceutical Preparations | 951 out of 963 | 1st |
Source: SEC filing on June 9, 2023.
Cauwenbergh's colleagues
We found two more compensation records of executives who worked with Geert Cauwenbergh at RXi Pharmaceuticals in 2022.